Risk of serious adverse events and death with low-dose methotrexate versus hydroxychloroquine in adults receiving dialysis
Muanda FT, Blake PG, Weir MA, Ahmadi F, Omrani MA, Abdullah SS, McArthur E, Sontrop JM, Urquhart BL, Garg AX. Semin Dial. 2026; May 12 [Epub ahead of print].